Product Code: ANV3140
REPORT HIGHLIGHT
Viral Vector Production Market size was valued at USD 1,298.43 Million in 2023, expanding at a CAGR of 17.5% from 2024 to 2032.
Genetically engineered viral vectors serve as vehicles to deliver specific genes or genetic material into cells, playing a vital role in biotechnology and gene therapy. Their primary functions include introducing therapeutic genes, rectifying genetic abnormalities, and modulating cellular functions. Adenoviruses (AdV), adeno-associated viruses (AAV), lentiviruses, retroviruses, among others, constitute the common types of viral vectors utilized in biotechnology. Adenoviral vectors, originating from adenoviruses responsible for human respiratory illnesses, and AAV vectors, derived from non-pathogenic viruses reliant on co-infection with helper viruses like adenoviruses for replication, are prominent examples. These versatile vectors find extensive applications across the biotechnology and pharmaceutical sectors, catalyzing significant advancements in gene therapy and biotechnological research. They have transformed these domains, facilitating the creation of innovative treatments and tools for elucidating and controlling genetic mechanisms.
Viral Vector Production Market- Market Dynamics
Rise in prevalence of cancer, infectious diseases, and genetic disorders to propel market demand
The surge in the prevalence of cancer, infectious diseases, and genetic disorders has profoundly influenced the market landscape. The escalating burden of these conditions has sparked a surge in demand for innovative therapies, notably gene therapy. Consequently, there's a corresponding uptick in the need for viral vectors to facilitate the development and manufacturing of gene therapies, as the prevalence of these ailments continues to climb. This trend has propelled the expansion of the viral vector production market. Moreover, the adoption of strategic maneuvers within the viral vector production market has further fueled its growth trajectory. Companies are deploying diverse strategies to bolster efficiency, expand production capacity, and enhance cost-effectiveness. By implementing these strategies, viral vector production firms can effectively meet the escalating demand for viral vectors, optimize production processes, and curtail manufacturing costs. These efforts are expected to underpin the continued growth of the market.
Viral Vector Production Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.5% over the forecast period (2024-2032)
Based on Vector Type segmentation, adeno-associated viruses were predicted to show maximum market share in the year 2023
Based on Indication segmentation, cancer was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
Viral Vector Production Market- Segmentation Analysis:
The Global Viral Vector Production Market is segmented based on Vector Type, Application, Indication, and Region.
The market is divided into five categories based on Vector Type: Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors and Other Viral Vectors. The adeno-associated viruses (AAV) vectors segment emerged as the dominant player in the viral vector production market, primarily driven by soaring demand in the gene therapy sector. According to the Alliance for Regenerative Medicine (ARM), AAV vectors constituted the primary vector used in gene therapy clinical trials, thereby fueling significant growth in this segment.
The market is divided into four categories based on Indication: Cancer, Genetic Disorders, Infectious Diseases and Other Diseases. In terms of indication, the cancer segment claimed the lion's share of the market revenue in 2023, owing to the pervasive prevalence of cancer worldwide. Statistics from the National Cancer Institute indicate an increasing number of new cancer cases and deaths in the U.S. alone in 2020. This widespread incidence of cancer has propelled the demand for advanced therapies like gene therapy, consequently driving the need for viral vector production in the development and research of such therapies.
Viral Vector Production Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America emerged as a major stronghold in the viral vector production market in 2023 and is poised to sustain its dominance in the forecast period. This growth can be attributed to the robust and well-established biotechnology and pharmaceutical industry in the region, equipped with advanced infrastructure and expertise in gene therapy and viral vector production. Additionally, the presence of leading biotech and pharmaceutical companies, research institutions, and academic centers further contributes to market expansion. Moreover, North America benefits from substantial government support and funding for research and development in the field of gene therapy and advanced therapeutics, positioning the region at the forefront of innovation and expediting the commercialization of viral vector-based therapies.
Viral Vector Production Market- Competitive Landscape:
In the Viral Vector Production market, companies employ various strategic initiatives such as partnerships, capacity expansion, and technological advancements to uphold their competitive edge. Collaborations with biotechnology firms, contract manufacturing organizations (CMOs), and academic research institutions provide access to specialized expertise, production facilities, and regulatory knowledge crucial for scalable viral vector manufacturing. These partnerships foster innovation in production processes, like suspension cell culture and transient transfection, enhancing viral vector yields and quality while reducing production costs and timelines. Additionally, ongoing capacity expansion endeavors ensure companies can meet the escalating demand for viral vectors in gene therapy, vaccine development, and cell therapy applications. Furthermore, investments in research and development enable the exploration of novel vector platforms, production technologies, and gene delivery strategies, augmenting the versatility and efficacy of viral vectors for therapeutic and research purposes. Through strategic partnerships and technological advancements, companies in the Viral Vector Production market fortify their market position, drive innovation, and contribute to advancements in biopharmaceuticals and regenerative medicine.
Recent Developments:
In July 2022, Takara Bio Inc. introduced a new Contract Development and Manufacturing Organization (CDMO) service utilizing a brain-tropic adeno-associated virus (AAV) vector called "CereAAV" for clients in the gene and cell therapy industry.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL VIRAL VECTOR PRODUCTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Danaher Corporation
TAKARA HOLDINGS INC.
Charles River Laboratories
Andelyn Biosciences
Thermo Fisher Scientific Inc.
Novartis AG
Avid Bioservices, Inc.
Lonza
FinVector O
Oxford Biomedica
Others
GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY VECTOR TYPE - MARKET ANALYSIS, 2019 - 2032
- Adenoviral Vectors
- Lentiviral Vectors
- Retroviral Vectors
- Adeno-Associated Viral Vectors
- Other Viral Vectors
GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
- Cancer
- Genetic Disorders
- Infectious Diseases
- Other Diseases
GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Viral Vector Production Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Viral Vector Production Market Snippet by Vector Type
- 2.1.2. Viral Vector Production Market Snippet by Application
- 2.1.3. Viral Vector Production Market Snippet by Indication
- 2.1.4. Viral Vector Production Market Snippet by Country
- 2.1.5. Viral Vector Production Market Snippet by Region
- 2.2. Competitive Insights
3. Viral Vector Production Key Market Trends
- 3.1. Viral Vector Production Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Viral Vector Production Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Viral Vector Production Market Opportunities
- 3.4. Viral Vector Production Market Future Trends
4. Viral Vector Production Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Viral Vector Production Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Viral Vector Production Market Landscape
- 6.1. Viral Vector Production Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Viral Vector Production Market - By Vector Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Vector Type, 2023 & 2032 (%)
- 7.1.2. Adenoviral Vectors
- 7.1.3. Lentiviral Vectors
- 7.1.4. Retroviral Vectors
- 7.1.5. Adeno-Associated Viral Vectors
- 7.1.6. Other Viral Vectors
8. Viral Vector Production Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Gene Therapy
- 8.1.3. Vaccinology
9. Viral Vector Production Market - By Indication
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 9.1.2. Cancer
- 9.1.3. Genetic Disorders
- 9.1.4. Infectious Diseases
- 9.1.5. Other Diseases
10. Viral Vector Production Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Viral Vector Production Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Viral Vector Production Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Viral Vector Production Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Viral Vector Production Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Viral Vector Production Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Viral Vector Production Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Danaher Corporation
- 11.2.2. TAKARA HOLDINGS INC.
- 11.2.3. Charles River Laboratories
- 11.2.4. Andelyn Biosciences
- 11.2.5. Thermo Fisher Scientific Inc.
- 11.2.6. Novartis AG
- 11.2.7. Avid Bioservices, Inc.
- 11.2.8. Lonza
- 11.2.9. FinVector O
- 11.2.10. Oxford Biomedica
- 11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us